The 135 Gene of Goatpox Virus Encodes an Inhibitor of NF-κB and Apoptosis and May Serve as an Improved Insertion Site To Generate Vectored Live Vaccine

J Virol. 2018 Aug 29;92(18):e00190-18. doi: 10.1128/JVI.00190-18. Print 2018 Sep 15.

Abstract

Goatpox virus (GTPV) is an important member of the Capripoxvirus genus of the Poxviridae Capripoxviruses have large and complex DNA genomes encoding many unknown proteins that may contribute to virulence. We identified that the 135 open reading frame of GTPV is an early gene that encodes an ∼18-kDa protein that is nonessential for viral replication in cells. This protein functioned as an inhibitor of NF-κB activation and apoptosis and is similar to the N1L protein of vaccinia virus. In the natural host, sheep, deletion of the 135 gene from the GTPV live vaccine strain AV41 resulted in less attenuation than that induced by deletion of the tk gene, a well-defined nonessential gene in the poxvirus genome. Using the 135 gene as the insertion site, a recombinant AV41 strain expressing hemagglutinin of peste des petits ruminants virus (PPRV) was generated and elicited stronger neutralization antibody responses than those obtained using the traditional tk gene as the insertion site. These results suggest that the 135 gene of GTPV encodes an immunomodulatory protein to suppress host innate immunity and may serve as an optimized insertion site to generate capripoxvirus-vectored live dual vaccines.IMPORTANCE Capripoxviruses are etiological agents of important diseases in sheep, goats, and cattle. There are rare reports about viral protein function related to capripoxviruses. In the present study, we found that the 135 protein of GTPV plays an important role in inhibition of innate immunity and apoptosis in host cells. Use of the 135 gene as the insertion site to generate a vectored vaccine resulted in stronger adaptive immune responses than those obtained using the tk locus as the insertion site. As capripoxviruses are promising virus-vectored vaccines against many important diseases in small ruminants and cattle, the 135 gene may serve as an improved insertion site to generate recombinant capripoxvirus-vectored live dual vaccines.

Keywords: GTPV 135; NF-κB pathway; apoptosis; viral vector.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / genetics*
  • Capripoxvirus / genetics*
  • Capripoxvirus / immunology
  • Capripoxvirus / pathogenicity
  • Genetic Vectors
  • HEK293 Cells
  • Hemagglutinins / genetics
  • Hemagglutinins / immunology
  • Humans
  • Immunity, Innate
  • Immunologic Factors / immunology
  • Mutagenesis, Insertional
  • NF-kappa B / antagonists & inhibitors*
  • NF-kappa B / genetics
  • Open Reading Frames / genetics
  • Peste-des-petits-ruminants virus / chemistry
  • Peste-des-petits-ruminants virus / genetics
  • Peste-des-petits-ruminants virus / immunology
  • Sheep
  • Vaccines, Attenuated / genetics
  • Vaccines, Attenuated / immunology
  • Viral Proteins / chemistry
  • Viral Proteins / genetics*
  • Viral Proteins / isolation & purification
  • Viral Vaccines / genetics*
  • Viral Vaccines / immunology

Substances

  • Hemagglutinins
  • Immunologic Factors
  • NF-kappa B
  • Vaccines, Attenuated
  • Viral Proteins
  • Viral Vaccines